DC
GSK icon

Deschaine & Company’s GSK GSK Stock Holding History

Deschaine & Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$856K Buy
16,451
+624
+4% +$35.1K 1.35% 30
2015
Q1 		$913K Sell
15,827
-804
-5% -$46.1K 1.5% 26
2014
Q4 		$889K Buy
+16,631
New +$930K 1.34% 27

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deschaine & Company's GSK Position: Q2 2015 in Review

Deschaine & Company increased its GSK (GSK) stake by 3.9% in Q2 2015, buying an estimated $35.1K and bringing the position to 16,451 shares worth $856K. The position accounts for 1.35% of the portfolio, ranked #30.

Deschaine & Company first reported a position in GSK in Q4 2014 and has held it in 3 quarters since. The position peaked at $913K in Q1 2015. 720 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • Deschaine & Company held 16,451 shares of GSK worth $856K as of Q2 2015.
  • Deschaine & Company bought 624 GSK shares in Q2 2015, an estimated $35.1K.
  • GSK made up 1.35% of Deschaine & Company's portfolio in Q2 2015, its #30 holding.
  • Deschaine & Company first reported a position in GSK in Q4 2014 and has held it in 3 quarters since.
  • Deschaine & Company's GSK position peaked at $913K in Q1 2015.
  • 720 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Deschaine & Company's 13F filing for Q2 2015, filed 30 Jul 2015.